These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2640481)

  • 1. [Immunologic studies in thalassemia major].
    Sen L; Goicoa MA; Nualart PJ; Ballart IJ; Palacios F; Diez RA; Estévez ME
    Medicina (B Aires); 1989; 49(2):131-4. PubMed ID: 2640481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload.
    Akbar AN; Fitzgerald-Bocarsly PA; de Sousa M; Giardina PJ; Hilgartner MW; Grady RW
    J Immunol; 1986 Mar; 136(5):1635-40. PubMed ID: 3005397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity and T subpopulations in thalassemia major.
    Neri A; Brugiatelli M; Iacopino P; Callea V; Ronco F
    Acta Haematol; 1984; 71(4):263-9. PubMed ID: 6232810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evaluation of β-thalassemia major patients receiving oral iron chelator deferasirox.
    Aleem A; Shakoor Z; Alsaleh K; Algahtani F; Iqbal Z; Al-Momen A
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):467-71. PubMed ID: 25052967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune status of Greek patients with beta-thalassemia major negative for anti-HIV.
    Choremi H; Sidiri E; Psarra K; Economidou J; Georgiopoulou P; Politi C; Roumeliotou A; Papaevangelou G
    Blut; 1987 May; 54(5):267-73. PubMed ID: 3105626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of natural killer (NK) function in carriers and patients with thalassemia major.
    Goicoa MA; Estevez ME; Ballart IJ; Diez RA; Peñalver JA; de Miani SA; Sen L
    Nouv Rev Fr Hematol (1978); 1986; 28(2):75-9. PubMed ID: 3737398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM
    Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
    Gharagozloo M; Karimi M; Amirghofran Z
    Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients.
    Kurtoğlu AU; Uğur S; Göçer M; Kurtoğlu E
    J Clin Lab Anal; 2024 May; 38(9):e25046. PubMed ID: 38814004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte changes in beta-thalassaemia major.
    Musumeci S; Schiliro G; Romeo MA; Sciotto A; Rosalba A; Pizzarelli G
    Arch Dis Child; 1979 Dec; 54(12):954-7. PubMed ID: 316991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-related immunologic abnormalities in beta-thalassemia major.
    Grady RW; Akbar AN; de Sousa M; Giardina PJ; Hilgartner MW
    Birth Defects Orig Artic Ser; 1987; 23(5A):587-93. PubMed ID: 3689945
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenetic aspects of immune deficiency associated with beta-thalassemia.
    Farmakis D; Giakoumis A; Polymeropoulos E; Aessopos A
    Med Sci Monit; 2003 Jan; 9(1):RA19-22. PubMed ID: 12552254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients.
    Al-Awadhi AM; Alfadhli SM; Al-Khaldi D; Borhama M; Borusly M
    Int J Lab Hematol; 2010 Apr; 32(2):191-6. PubMed ID: 19453575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive dysfunction of monocytes associated with iron overload and age in patients with thalassemia major.
    Ballart IJ; Estevez ME; Sen L; Diez RA; Giuntoli J; de Miani SA; Peñalver J
    Blood; 1986 Jan; 67(1):105-9. PubMed ID: 3940540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-related disturbances of cell-mediated immunity in multitransfused children with thalassemia major.
    Pardalos G; Kanakoudi-Tsakalidis F; Malaka-Zafiriu M; Tsantali H; Athanasiou-Metaxa M; Kallinikos G; Papaevangelou G
    Clin Exp Immunol; 1987 Apr; 68(1):138-45. PubMed ID: 3498564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in the immune system of children with beta-thalassaemia major.
    Dwyer J; Wood C; McNamara J; Williams A; Andiman W; Rink L; O'Connor T; Pearson H
    Clin Exp Immunol; 1987 Jun; 68(3):621-9. PubMed ID: 3498580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological profile after splenectomy in children with beta-thalassaemia major.
    Mandalenaki-Lambrou K; Vrachnou E; Calogeropoulou C; Ladis V; Kattamis C
    Acta Haematol; 1987; 78(4):243-8. PubMed ID: 3122490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
    Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired phagocyte antibacterial effector functions in beta-thalassemia: a likely factor in the increased susceptibility to bacterial infections.
    Wiener E
    Hematology; 2003 Feb; 8(1):35-40. PubMed ID: 12623425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.
    Casale M; Cinque P; Ricchi P; Costantini S; Spasiano A; Prossomariti L; Minelli S; Frega V; Filosa A
    Eur J Haematol; 2013 Jul; 91(1):69-73. PubMed ID: 23581970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.